Cargando…
Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment
Background. Currently, there are no tools to accurately predict tuberculosis relapse. This study aimed to determine whether patients who experience tuberculosis relapse have different immune responses to mycobacteria in vitro than patients who remain cured for 2 years. Methods. Patients with an init...
Autores principales: | Cliff, Jacqueline M., Cho, Jang-Eun, Lee, Ji-Sook, Ronacher, Katharina, King, Elizabeth C., van Helden, Paul, Walzl, Gerhard, Dockrell, Hazel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704670/ https://www.ncbi.nlm.nih.gov/pubmed/26351358 http://dx.doi.org/10.1093/infdis/jiv447 |
Ejemplares similares
-
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis
por: Eckold, Clare, et al.
Publicado: (2020) -
Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
por: Ronacher, Katharina, et al.
Publicado: (2019) -
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment
por: van Doorn, Cassandra L.R., et al.
Publicado: (2022) -
PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
por: Hassan, Syeda S., et al.
Publicado: (2015) -
CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
por: Hasan, Zahra, et al.
Publicado: (2009)